Article

China’s medical device development process-under COVID-19(2)

2. From follower to challenger

However, due to the wide variety of medical devices and the obvious differentiation of market segments, the speed of their development and evolution is naturally different. The fields of IVD, imaging diagnosis and orthopedics have basically experienced the above-mentioned typical development stages. However, in some newly emerging technical fields, such as minimally invasive surgical instruments suitable for thoracic and abdominal surgery (thoracoscopic and laparoscopic various minimally invasive instruments such as staplers, trocars, ultrasonic scalpels, etc.) Consumables) Due to the accumulation and reference of the entire industry experience in the second stage, the learning curve has been greatly shortened, and there has been a very rapid industry evolution and development, and it is very possible to achieve overtaking on a curve.

Since the first batch of domestic manufacturers of endoscopic staplers appeared in China in the middle of 2000, although it has been nearly 15 years since the development, endoscopic staplers are still a highly fragmented market segment. Nearly a hundred domestic stapler manufacturers are scattered in Jiangsu, Shanghai and Beijing. More than 30 manufacturers of endoscopic staplers have gathered in Changzhou, Jiangsu Province, which is an important town for domestic staplers. However, most of these manufacturers have duplicated product technologies, lack of innovation, and the output value is mostly concentrated in the tens of millions of scales. As a result, the technical level and market share of the overall domestic endoscope stapler still has a large gap with imported brands. The entire industry urgently needs to be effectively integrated to eliminate truly outstanding leading companies. According to statistics from Zhiyan Consulting, China's endoscopic stapler market has grown from 500 million yuan in 2009 to 5.5 billion yuan in 2018, with an average annual compound growth rate of 27.10% over the past decade, and its growth rate far exceeds that of open staplers. The momentum is close to the development of the IVD industry from 2000 to 2010. The huge market scale, the increasingly mature clinical applications, combined with the national centralized procurement policy and industry trends force companies to upgrade their product technology through innovation and creation. We have reason to believe that truly powerful head companies will inevitably start The stapler was born in the market segment.

surgaid medical

Fortunately, this inference has been verified by the facts that are happening. The entire industry has entered the third stage, that is, after 2010, there have been some positive trends in the endoscopic stapler market segment: Some outstanding companies have begun to attach importance to R&D and increase investment in technology; in terms of business layout, they have increased their active expansion in the international market, gradually getting rid of the traditional trade-style export pattern, and are gradually forming a two-wheel-driven business growth model in the domestic and international markets.

Surgaid Medical (Xiamen) Co., Ltd

Surgaid Medical (Xiamen) Co., Ltd has been committed to surgical product development ,production and marketing for 10 more years . In particular, minimally invasive surgical products. Minimally invasive surgery is a surgical direction of development. Such as Disposable Laparoscopic Trocar, Linear Cutter Stapler, Circular Stapler, PPH, and so on.

Manufacturing our own Surgical products allows us to have complete control over the design and evolution of our products. We are able to adapt quickly to the constantly evolving healthcare market and offer high quality, single-use, cost-effective solutions that directly compete with global market-leaders.

Surgaid products:

For more product information at https://www.surgaid-medical.com/